Induced pluripotent stem cells (iPSCs) have been generated by enforced expression of defined sets of transcription factors in somatic cells. It remains controversial whether iPSCs are molecularly and functionally equivalent to blastocyst-derived embryonic stem (ES) cells. By comparing genetically identical mouse ES cells and iPSCs, we show here that their overall messenger RNA and microRNA expression patterns are indistinguishable with the exception of a few transcripts encoded within the imprinted Dlk1-Dio3 gene cluster on chromosome 12qF1, which were aberrantly silenced in most of the iPSC clones. Consistent with a developmental role of the Dlk1-Dio3 gene cluster, these iPSC clones contributed poorly to chimaeras and failed to support the development of entirely iPSC-derived animals ('all-iPSC mice'). In contrast, iPSC clones with normal expression of the Dlk1-Dio3 cluster contributed to high-grade chimaeras and generated viable all-iPSC mice. Notably, treatment of an iPSC clone that had silenced Dlk1-Dio3 with a histone deacetylase inhibitor reactivated the locus and rescued its ability to support full-term development of all-iPSC mice. Thus, the expression state of a single imprinted gene cluster seems to distinguish most murine iPSCs from ES cells and allows for the prospective identification of iPSC clones that have the full development potential of ES cells.
Induced pluripotent stem cells (iPSCs) have been generated by enforced expression of defined sets of transcription factors in somatic cells. It remains controversial whether iPSCs are molecularly and functionally equivalent to blastocyst-derived embryonic stem (ES) cells. By comparing genetically identical mouse ES cells and iPSCs, we show here that their overall messenger RNA and microRNA expression patterns are indistinguishable with the exception of a few transcripts encoded within the imprinted Dlk1-Dio3 gene cluster on chromosome 12qF1, which were aberrantly silenced in most of the iPSC clones. Consistent with a developmental role of the Dlk1-Dio3 gene cluster, these iPSC clones contributed poorly to chimaeras and failed to support the development of entirely iPSC-derived animals ('all-iPSC mice'). In contrast, iPSC clones with normal expression of the Dlk1-Dio3 cluster contributed to high-grade chimaeras and generated viable all-iPSC mice. Notably, treatment of an iPSC clone that had silenced Dlk1-Dio3 with a histone deacetylase inhibitor reactivated the locus and rescued its ability to support full-term development of all-iPSC mice. Thus, the expression state of a single imprinted gene cluster seems to distinguish most murine iPSCs from ES cells and allows for the prospective identification of iPSC clones that have the full development potential of ES cells.
Induced pluripotent stem cells (iPSCs), generated by the overexpression of transcription factors such as Oct4 (also called Pou5f1), Sox2, Klf4 and c-Myc in somatic cells 1, 2 , have enormous therapeutic potential as they enable the derivation of patient-specific pluripotent cell lines to study and possibly treat degenerative diseases. Although the generation of iPSCs is technically simple and ethically uncontroversial, it remains unclear whether iPSCs are molecularly and functionally different from ES cells derived from blastocysts, which are considered the gold standard for pluripotent cells. Previously published reports indicate high similarities between ES cells and iPSCs, including indistinguishable global histone modification and DNA methylation patterns 3, 4 . In addition, iPSCs, like ES cells, give rise to numerous differentiated cell types, including the germ line, in the context of chimaeric animals 5, 6 . More recently, iPSCs have been shown to support the development of all-iPSC mice using tetraploid (4n) embryo complementation [7] [8] [9] , the most stringent assay for developmental potential 10, 11 . Despite these similarities, there is emerging evidence for substantial differences between ES cells and iPSCs. For example, most iPSC clones give rise to low-grade chimaeras after injection into diploid blastocysts and fail to support the development of postnatal all-iPSC mice upon 4n embryo complementation [12] [13] [14] . At the molecular level, major differences in mRNA and microRNA (miRNA) expression [15] [16] [17] , as well as in DNA methylation [18] [19] [20] , have been reported between ES cells and iPSCs. These observations indicate that factormediated reprogramming results in abnormalities in resultant iPSCs, which could impede their therapeutic utility. In contrast, nucleartransfer-mediated reprogramming gives rise to nuclear transfer ES cells that are molecularly and functionality indistinguishable from ES cells derived from fertilized embryos 21, 22 , raising the possibility that nuclear transfer generates cells that are more completely reprogrammed than iPSCs.
A potential limitation of the aforementioned studies is that ES cells were compared with iPSCs of different genetic backgrounds and harbouring viral transgenes, which are known to affect gene expression patterns 21, 23 and the functionality 1, 6 of cells. We therefore revisited the question of whether ES cells and iPSCs are equivalent by comparing genetically matched cell lines.
Transcriptional comparison of ES cells and iPSCs
To circumvent the potentially confounding effects of genetic background and viral integrations on gene expression patterns and developmental potential, we used a novel transgenic reprogramming system to generate genetically matched mouse ES cells and iPSCs 24 . Briefly, a polycistronic cassette expressing Oct4, Klf4, Sox2 and c-Myc 25 (OKSM) under the control of a doxycycline-inducible promoter was inserted into the collagen type I a1 (Col1a1) locus of ES cells expressing the reverse tetracycline-dependent transactivator (rtTA) from the ROSA26 promoter 26 . These collagen-OKSM ES cells were then used to generate mice from which different somatic cell types were isolated and induced with doxycycline to derive genetically matched iPSCs for molecular and functional comparisons (Fig. 1a, b) .
We first compared the abilities of parental collagen-OKSM ES cells and iPSCs derived from mouse embryonic fibroblasts (MEFs) to support the development of all-iPSC mice using 4n embryo complementation. The two tested ES cell lines gave rise to viable mice at expected frequencies (13-20%) 11 , demonstrating that the OKSM transgene per se does not adversely affect development (Supplementary Table 1 ). In contrast, all four tested iPSC lines repeatedly failed to support the development of all-iPSC mice, indicating qualitative differences between these iPSCs and ES cells (Supplementary Table 1) .
We reasoned that a transcriptional comparison of the iPSC lines that failed 4n complementation with matched 4n-complementationcompetent ES cell lines might reveal molecular changes that explain the developmental deficits of iPSCs. Global mRNA profiling showed marked similarities in the overall transcriptional patterns of four collagen-OKSM ES cells and six derivative iPSCs and did not separate these cell lines using unsupervised clustering or principal component analysis (Fig. 1c and data not shown) . In fact, only two transcripts were identified as differentially expressed (.2-fold difference, t-test, P , 0.05) between ES cells and iPSCs. These were the non-coding RNA Gtl2 (also know as Meg3) and the small nucleolar RNA Rian (Fig. 1d, e) .
Repression of Dlk1-Dio3 transcripts in iPSCs
Gtl2 and Rian localize to the imprinted Dlk1-Dio3 gene cluster on mouse chromosome 12qF1 and are maternally expressed in mammals (Fig. 1f) 
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. Both genes were strongly repressed in iPSC clones compared to ES cell clones, whereas expression of pluripotency and housekeeping genes remained unaffected (Fig. 1e) . Quantitative PCR (qPCR) analysis of Gtl2, Rian and Mirg, another maternally expressed imprinted gene in the Dlk1-Dio3 cluster, confirmed transcriptional silencing in iPSCs ( Supplementary Fig. 1a ). Expression of other imprinted genes showed clone-to-clone variations, as was previously seen for ES cells 28 , but no consistent differences between ES cells and iPSCs ( Fig. 1e and Supplementary Table 2 ). This shows that imprinted gene silencing is not a genome-wide phenomenon. Of note, we failed to detect differences with the collagen-OKSM system in the expression of ,300 transcripts that have recently been reported to be differentially regulated in a comparison of mouse and human iPSCs with ES cells 15 ( Supplementary Fig. 2a ). However, silencing of Gtl2 was also evident in the murine-specific iPSC data set used in that study ( Supplementary Fig. 2c ). Together, these data indicate that a relatively small set of transcripts distinguishes genetically matched iPSCs and ES cells, and suggest that many of the previously seen differences are probably due to variations in genetic background or viral transgene insertions.
Imprinting of the Dlk1-Dio3 locus is accompanied by differential expression of about 50 miRNAs (Fig. 1f ) 29, 30 . We therefore performed genome-wide miRNA profiling on the same samples as analysed for mRNA expression. Of 336 miRNAs detected, 21 (6.3%) were differentially expressed between all ES cell and iPSC clones analysed (Fig. 1g and Supplementary Table 3 ). All of these miRNAs localized to chromosome 12qF1 and were silenced in iPSCs, thus corroborating the notion that most iPSCs show aberrant silencing of this major imprinting domain.
To determine the generality of Gtl2 silencing in iPSCs, we measured its expression in 61 additional iPSC lines derived from haematopoietic stem cells (11 lines), granulocyte-macrophage progenitors (11 lines), granulocytes (9 lines), peritoneal fibroblasts (6 lines), tail-tip fibroblasts (6 lines) and keratinocytes (18 lines) . Only four of these lines (5.8%), originating from either peritoneal or tail-tip fibroblasts, showed Gtl2 expression levels similar to those of ES cells (termed 'Gtl2 on clones') ( Fig. 2a and Supplementary Fig. 1b, c) . The finding that the vast majority of iPSC clones showed transcriptional suppression of Gtl2 (termed 'Gtl2 off clones') demonstrates that silencing of this locus occurs in iPSCs derived from different cell types at various stages of differentiation. Analysis of published microarray data sets comparing ES cells and iPSCs generated from mouse fibroblasts, neural and bone marrow cells also showed repression of maternally expressed 12qF1 transcripts ( Supplementary Fig. 2b-e) , supporting the notion that silencing of this cluster is a common outcome upon factor-mediated reprogramming.
Developmental effects of Dlk1-Dio3 silencing Dysregulation of genes within the Dlk1-Dio3 cluster can be detrimental during pre-and postnatal mouse development [31] [32] [33] [34] [35] . To assess whether the expression status of Gtl2 and its associated transcripts correlates with the developmental potential of iPSCs, we injected nine Gtl2 off clones into diploid blastocysts. This resulted in adult chimaeras that exhibited low-to-medium degree (10-50%) coat colour chimaerism (Fig. 2b-e and Supplementary Table 4 ). In contrast, injection of three Gtl2 on iPSC clones yielded adult mice with a coat colour chimaerism ranging from 30% to 100%, similar to the chimaerism seen with ES cells (Fig. 2d , e and Supplementary Table 4) . Importantly, four out of four Gtl2 on iPSC clones supported the development of neonatal all-iPSC mice upon injection into 4n blastocysts at efficiencies comparable to those observed with ES cells (7-19% for iPSCs compared with 13-20% for ES cells) (Supplementary Table 1 ). We confirmed that these mice were entirely iPSCderived by PCR for strain-specific polymorphisms ( Supplementary  Fig. 3 ), by detection of homogenous GFP fluorescence of all-iPSC neonates, originating from a ROSA26-EGFP allele introduced into the parental ES cells, and by uniform agouti coat colour of adolescent all-iPSC mice (Fig. 2f ). To our knowledge, this is the first demonstration of animals produced entirely from adult-derived iPSCs.
In contrast to Gtl2 on iPSC clones, injection of ten Gtl2 off iPSC clones into 4n blastocysts consistently failed to produce all-iPSC pups but instead resulted in resorptions (Supplementary Table 1 ). Thus, the expression status of Gtl2 in these iPSCs predicts their developmental potential into chimaeric and all-iPSC mice. The conclusion that the activation status of maternally expressed genes on chromosome 12qF1 is a strong indicator of the developmental potential of iPSCs was further supported by the analysis of two published array data sets, which showed that Gtl2 was expressed in 4n complementation-competent ES cell and iPSC lines but was downregulated in non-4n complementation-competent iPSC lines 8, 9 ( Supplementary Fig. 4 ). To test whether Gtl2 on and Gtl2 off iPSCs can be distinguished by the expression of genes outside of 12qF1, we performed global mRNA and miRNA expression profiling of four non-4n complementationcompetent and four 4n complementation-competent iPSC lines (all derived from fibroblasts). This analysis identified only Gtl2, Rian and a total of 26 miRNAs, which all localize to the Dlk1-Dio3 cluster, as differentially expressed, suggesting that the dysregulation of 12qF1 transcripts alone is responsible for the failure of Gtl2 off iPSCs to support the development of all-iPSC mice ( Fig. 2g and Supplementary Table 5 ).
Epigenetic mechanism of Dlk1-Dio3 repression Imprinting of the Dlk1-Dio3 cluster is regulated by differentially methylated regions (DMRs) that become epigenetically modified in the germ line. These include an intergenic DMR (IG-DMR), located between the Dlk1 and Glt2 genes 19 , and a DMR spanning the Gtl2 promoter (Gtl2 DMR) 15 . To determine whether aberrant DNA methylation might be responsible for the transcriptional silencing seen in Gtl2 off iPSC lines, we compared the methylation status of IG-DMR, Gtl2 DMR and three other CpG-rich regions on chromosome 12qF1 in ES cells, iPSCs and their parental tail-tip fibroblasts (Fig. 3a) . As expected for germline-imprinted regions, Clone: approximately 50% of CpGs within IG-DMR and Gtl2 DMR were methylated in fibroblasts, ES cells and Gtl2 on iPSCs. In contrast, close to 100% of these CpGs were methylated in Gtl2 off iPSC lines ( Fig. 3b  and Supplementary Fig. 5 ). The other analysed CpG-rich regions remained unaffected (Supplementary Fig. 5 ). Imprinting of the Dlk1-Dio3 cluster is also regulated by histone acetylation 36 , and chromatin immunoprecipitation experiments indeed revealed a significant decrease in acetylated H3 and H4 as well as in methylated H3K4, another activation mark, in Gtl2 off iPSC lines compared with Gtl2 on iPSC lines and ES cells (Fig. 3c) . Together, these observations demonstrate that the normally expressed maternal Gtl2 allele has acquired an aberrant paternal-like silent state in Gtl2 off iPSC clones. Because imprinted gene expression is unstable in murine ES cells 28, 37 , we assessed Gtl2 expression upon subcloning of iPSCs. Gtl2 remained silent in subclones from Gtl2 off iPSCs and continued to be expressed in subclones from Gtl2 on iPSCs, demonstrating stability of its expression state in undifferentiated cells (Fig. 3d,  top) . This pattern was not altered if doxycycline was administered during the subcloning procedure (Fig. 3d, bottom) , indicating that overexpression of the reprogramming factors in established iPSCs is insufficient to induce or revert silencing.
To assess if silencing of Gtl2 is resolved during differentiation, we exposed iPSCs and ES cells to the differentiation-stimulating agent retinoic acid. Marked changes in cellular morphology and downregulation of Pou5f1 indicated successful differentiation (Fig. 3e, f) . Whereas retinoic-acid-treated Gtl2 on iPSCs and ES cells readily upregulated Gtl2 (Fig. 3f, top) and Rian ( Supplementary Fig. 6 ), Gtl2 off iPSCs showed stable silencing of these genes, demonstrating that in vitro differentiation fails to reactivate maternally imprinted genes in the Dlk1-Dio3 cluster. The expression of imprinted genes outside of chromosome 12qF1 was not affected (Fig. 3f, bottom, and Supplementary Fig. 6 ).
We next sought to gain an insight into the causes for the failure of Gtl2 off iPSCs to produce viable all-iPSC mice. To this end, we determined if these cells could autonomously support development into early embryos. Indeed, injection of both Gtl2 off and Gtl2 on iPSC clones into 4n blastocysts gave rise to normal-appearing mid-gestation (embryonic day (E) 11.5) embryos (Fig. 4a) . However, the number of live embryos obtained from Gtl2 off clones was substantially reduced compared with Gtl2 on clones (Fig. 4b) , suggesting that Gtl2 off mice die around this developmental stage. This phenotype resembles that of mice with paternal uniparental disomy of distal chromosome 12 38 , which die before E16.5, but is distinct from the phenotype of maternal Gtl2 knockout mice (Gtl2 mKO ), which die perinatally 31 . The less severe phenotype of Gtl2 mKO embryos might be due to the comparably modest reduction in maternally expressed 12qF1 genes 31 . In agreement with this notion, we found low but detectable levels of Rian and Mirg transcripts in Gtl2 mKO MEFs (Fig. 4c ), whereas these genes were almost completely silenced in MEFs and different tissues derived from Gtl2 off all-iPSC embryos (Fig. 4d, e) . Notably, expression of the Dlk1 gene, which is reciprocally imprinted to Gtl2 (ref. 39) , was upregulated in Gtl2 off MEFs but not in Gtl2 mKO MEFs (Fig. 4c) , further supporting the observation that the maternal Dlk1-Dio3 cluster has acquired a paternal-like expression state in Gtl2 off iPSCs. Accordingly, IG-DMR and Gtl2 DMR were hypermethylated in Gtl2 off MEFs but remained unaffected in Gtl2 mKO MEFs (Fig. 4f) . Together, these observations are in agreement with the notion that stable epigenetic silencing of the Dlk1-Dio3 locus is the cause for the developmental failure of Gtl2 off all-iPSC embryos.
Reversal of epigenetic silencing in Gtl2 off iPSCs ES cells derived from cloned embryos are transcriptionally indistinguishable from ES cells produced from fertilized embryos and support the development of all-ES-cell mice, regardless of donor cell identity 21, 22, 40, 41 , indicating that nuclear transfer generates faithfully reprogrammed pluripotent cells (Supplementary Fig. 7a ). In agreement with this observation, we found that Gtl2 was expressed in previously characterized 4n complementation-competent nuclear transfer ES cell lines derived from fibroblasts and haematopoietic cells 21 ( Supplementary Fig. 7b ). We next tested whether nuclear transfer could reverse the aberrant silencing of genes within the Dlk1-Dio3 cluster in Gtl2 off iPSCs and rescue their ability to support the development of all-iPSC mice ( Supplementary Fig. 7c ). We derived nine nuclear transfer ES cell lines 42 from Gtl2 off iPSCs that had been generated from tail-tip fibroblasts and fetal liver cultures using adenoviral vectors 43 or from haematopoietic stem cells and granulocytes using the collagen-OKSM system. Some of these iPSCs were germline competent 43 , indicating that they were genetically normal, but failed to give rise to all-iPSC mice (Supplementary Table 6 ). Global transcriptome analysis showed no consistent differences in mRNA and miRNA expression between nuclear transfer ES cells and the donor iPSC clones. Importantly, Gtl2 and Rian remained repressed in all lines (Supplementary Fig. 7d ). Accordingly, these cells failed to generate all-iPSC mice (Supplementary Table 6 ), indicating that nuclear transfer cannot reset the faulty gene expression pattern acquired during iPSC generation. This notion is consistent with the previous finding that aberrant genomic imprints present in donor cells cannot be restored in cloned animals after nuclear transfer 28 .
Given that Gtl2
off iPSC clones showed reduced histone acetylation at the Gtl2 locus (Fig. 3c) , we wondered whether their treatment with the histone deacetylase inhibitor valproic acid (VPA) could reactivate the silenced gene cluster. Indeed, 2 out of 21 subclones treated with VPA exhibited increased Gtl2 expression with one iPSC clone showing expression levels comparable to ES cells (Fig. 4g) . Consistent with transcriptional reactivation of the cluster, we found re-appearance of H3 acetylation and H3K4 methylation at the Gtl2 locus (Supplementary Fig. 8 ). Injection of this rescued clone into 4n blastocysts gave rise to apparently normal E11.5 embryos at frequencies similar to those seen with Gtl2 on iPSC clones ( Fig. 4b and Supplementary  Fig. 9a ). These embryos expressed Gtl2, Rian and Mirg (Supplementary Fig. 10a ) and showed normal expression levels of tissue-specific marker genes such as Ascl1 (also known as Mash-1) and Hes5 that were repressed in Gtl2 off embryos (Supplementary Fig. 10b ). Importantly, the rescued clone supported the development of several full-term all-iPSC pups, which was never seen with the parental iPSCs or any other Gtl2 off iPSC clone ( Fig. 4h and Supplementary Fig. 9b ). These pups were severely overgrown, however, and hence non-viable. We surmise that the elevated levels of Dlk1 in the rescued clone ( Supplementary Fig. 10a ) is responsible for this phenotype, as overexpression of this gene causes neonatal lethality owing to fetal overgrowth 34 . Alternatively, VPA treatment may have caused the dysregulation of other genes even though we found no aberrant expression of several candidate imprinted genes implicated in growth control ( Supplementary Fig. 10c ).
Discussion
Our data indicate that the expression of a surprisingly small number of transcripts, which localize to a single cluster in the genome, distinguishes most mouse iPSCs from ES cells and is predictive for their developmental potential. Silencing of Dlk1-Dio3 was seen in iPSCs derived from different cell types and using various reprogramming approaches, including the collagen-OKSM system as well as retroviral and adenoviral transduction, suggesting that aberrant repression of this locus is a general consequence of factor-mediated reprogramming in mouse cells. It remains to be tested, however, (1) if other consistent expression changes exist in iPSCs that are not detectable in the undifferentiated state or with current profiling technology; (2) whether iPSC-specific non-recurrent genetic and epigenetic aberrations are present in only some clones; and (3) if iPSCs derived from more defined cell populations than fibroblasts exhibit cell-oforigin-specific transcriptional and epigenetic patterns in addition to the observed silencing of Gtl2. It is noteworthy in this respect that all of the Gtl2 on iPSC clones described here or published previously were derived from fibroblast cultures, which express high levels of Gtl2, whereas the reprogramming of haematopoietic cells, which exhibit low Gtl2 levels, uniformly yielded Gtl2 off iPSC clones. This observation raises the question of whether the expression status of Gtl2 in the somatic cell of origin may affect silencing of the locus in resultant iPSCs and whether Gtl2 on iPSC clones can be derived from somatic cells other than fibroblasts. Another important point that needs to be addressed is whether similar expression abnormalities are seen in human iPSCs. Although a preliminary evaluation of published expression data 44 did not indicate aberrant regulation of the Gtl2 homologue MEG3 in human iPSCs compared with ES cells, our observations in mouse suggest that a meaningful answer to this question requires the establishment of genetically matched human ES cells and iPSCs.
Epigenetic analysis of the Dlk1-Dio3 locus indicates that the stable repression of maternally expressed genes in Gtl2 off iPSC clones is due to DNA hypermethylation and hypoacetylation of key imprint control regions, leading to a 'paternalization' of the maternally inherited Dlk1-Dio3 cluster. The homogeneous expression levels of Gtl2 in fibroblasts and the observation that nuclear transfer ES cells derived from various cell types express normal levels of Gtl2 rule out the possibility that aberrant silencing of the locus pre-existed in the somatic cell of origin. Rather, the iPSC reprogramming procedure itself seems to introduce these epigenetic changes by an as-yetundefined mechanism that may point towards an involvement of one or more of the reprogramming factors in the control of Gtl2 in germ cells, where imprints are established. Notably, the pluripotency factors Oct4 and Sox2, which are both expressed in germ cells, have been recently implicated in the regulation of the Xist and Tsix transcripts that control epigenetic silencing of the X chromosome in female embryos 45, 46 . Our findings also support the notion that nuclear transfer generates faithfully reprogrammed cells more frequently than factor-mediated reprogramming. A better understanding of the causes for the specific silencing of the Dlk1-Dio3 cluster during iPSC formation will shed light on the molecular mechanisms of reprogramming as well as on the epigenetic regulation of this particular locus. These studies may also lead to improved reprogramming strategies, such as alternative factor combinations or modified culture conditions, that faithfully establish a fully pluripotent state in somatic cells.
METHODS SUMMARY
ES cells and iPSCs were cultured in ES cell media containing 15% FBS and 1,000 U ml 21 LIF. For the reprogramming of somatic cells the media was supplemented with 1 ng ml 21 doxycycline and, for haematopoietic cell reprogramming, with cell-type-specific cytokines 24, 47 . For qPCR and microarray analyses, ES cells or iPSCs were trypsinized and pre-plated onto cell culture flasks for 45 min to remove feeder cells. Total RNA was extracted from the non-adherent cell suspension using the miRNeasy kit (Qiagen). Microarrays were done using 430 2.0 and 430A 2.0 chips (Affymetrix) followed by analysis with GeneSifter software for mRNAs or using the miRCURY LNA array platform (Exiqon). Injections into diploid and tetraploid BDF1 blastocysts were done as described previously 11 .
METHODS
Cell culture. ES cells and iPSCs were cultured in ES cell medium (DMEM with 15% FBS, L-glutamin, penicillin-streptomycin, non-essential amino acids, b-mercaptoethanol and 1,000 U ml 21 LIF) on irradiated feeder cells. Mouse embryonic fibroblasts (MEFs) were isolated by trypsin digestion of mid-gestation (E14.5) ES-cell-chimaeric embryos followed by culture in fibroblast medium (DMEM with 10% FBS, L-glutamin, penicillin-streptomycin, non-essential amino acids and b-mercaptoethanol). A total of 1 mg ml 21 puromycin was added to these cultures for 5 days to select for ES-cell-derived cells. Tail-tip fibroblast (TTF) cultures were established by trypsin digestion of tail-tip biopsies taken from newborn (3-8 days of age) chimaeric mice derived after blastocyst injection of ROSA26-EGFP targeted ES cells. ES-cell-derived cells were isolated based on GFP expression and maintained in fibroblast medium. For the establishment of peritoneal fibroblast cultures, adult mice were killed and 1-2 cm 2 of peritoneal body wall isolated and chopped into small pieces in 0.25% trypsin/EDTA in a 35-mm cell culture vessel. After 5 min of incubation at 37 uC, 6 ml fibroblast medium was added and the tissue re-suspended several times through a pipette. Peritoneal fibroblast cultures were maintained and propagated like MEF and TTF cultures. To derive iPSCs from fibroblast cultures, cells were trypsinized and seeded on top of irradiated feeder layers in fibroblast medium. The next day, ES cell medium containing 1 mg ml 21 doxycycline was added and replenished every 3 days. Doxycycline was withdrawn after 10-20 days and colonies picked that maintained ES cell morphology after another 4 days of culture in regular ES cell medium. Haematopoietic cells were isolated from bone marrow as previously described 47 . Briefly, freshly isolated mononucleated bone marrow cells were separated into the desired subfractions by FACS using the following surface marker combinations: CD150 ). Doxycycline was withdrawn after 2 weeks and colonies with ES cell morphology picked after another 4 days of culture in regular ES cell medium. For the establishment of keratinocyte cultures the back skin of newborn mice was placed onto 0.25% trypsin (epidermis facing up) and cultured overnight at 4 uC. Using fine forceps, the epidermis was then separated from the dermis and incubated in 0.25% trypsin at 37 uC for 15 min, followed by mechanical dissociation using a pipette. Cells were then filtered using a 40 mm strainer and cultured in CnT-07 medium (CELLnTEC). After 2 weeks of culture, keratinocytes were further purified by FACS sorting using the surface marker combination CD49f
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. Sorted cells were seeded on top of irradiated feeder layers in CnT-07 medium containing doxycycline, which was replaced with ES cell medium plus doxycycline after 3 days. Doxycycline was withdrawn after a total of 14 days and colonies picked on day 20. Generation of OKSM ES cells. A polycistronic cassette encoding Oct4, Klf4, Sox2 and c-Myc (previously called STEMCCA 25 ) was cloned into the shuttle plasmid pBS31 using NotI/ClaI digestion. The resulting plasmid was electroporated into KH2 ES cells 26 together with a plasmid driving expression of Flp recombinase. Correctly targeted clones were isolated by hygromycin selection and confirmed by Southern blot analysis as previously described 26 . Individual OKSM ES cell subclones were gene targeted with ROSA26-EGFP as has been described before 48 to facilitate tracking of ES-cell-derived cells after blastocyst injection. OKSM ES cells and derivative mice are described in detail elsewhere 24 . Quantitative PCR. ES cells and iPSCs grown on 35-mm dishes were harvested when they reached about 50% confluency and pre-plated on non-gelatinized T25 flasks for 45 min to remove feeder cells. Cells were spun down and the pellet used for isolation of total RNA using the miRNeasy Mini Kit (Qiagen) without DNase digestion. RNA was eluted from the columns using 50 ml RNase-free water or Tris-EDTA (TE) buffer, pH 7.5 (10 mM Tris-HCl and 0.1 mM EDTA) and quantified using a NanoDrop spectrophotometer (Thermo Scientific). cDNA was produced with the First Strand cDNA Synthesis Kit (Roche) using 1 mg of total RNA input. Real-time quantitative PCR reactions were set up in triplicate using 5 ml of cDNA (1:100 dilution) with the Brilliant II SYBR Green QPCR Master Mix (Stratagene) and run on a Mx3000P QPCR System (Stratagene). Primer sequences are listed in Supplementary Table 7 . Transcriptome profiling. Analysis of mRNA expression by Affymetrix GeneChip 430 2.0 microarray (used for comparing nuclear transfer ES cells and parental iPSCs) was performed similarly to the method described previously 49 . Briefly, total RNA samples were subjected to Lab-on-a-Chip RNA analysis to determine their RNA integrity number (RIN). Biotinylated antisense cRNA probes were synthesized for RNA samples with 9.0 or greater RIN using Affymetrix One-Cycle target labelling and control reagents (for cDNA synthesis) and Enzo Bioarray high-yield RNA transcript labelling kit (for cRNA synthesis and labelling). Labelled probes were hybridized to microarrays overnight. Microarray chips were then stained with avidin-conjugated phycoerythrin fluorescence dye and washed using Affymetrix Fluidics Station 450 (protocol: EukGEWS2v5_450). Arrays were scanned by an Affymetrix 3000-7G scanner, and .CHP data files were generated by GCOS using the statistical algorithm and scaling (target intensity value 5 150). Hierarchical clustering was performed using Cluster software and visualized by TreeView software 50 . For analysis using Affymetrix 430A 2.0 arrays (all other samples), RNA was amplified using the Nugen Ovation amplification system using the manufacturer's protocol. Amplified samples were normalized to 17 ng ml 21 and 1.5 mg of total cDNA was hybridized to the arrays for 16 h at 45 uC. Arrays were washed and scanned using the HT Array Plate Scanner according to the manufacturer's protocol. GeneSifter microarray data analysis server (Geospiza) was used for statistical analyses. For miRNA analysis, total RNA was subjected to quality control consisting of RNA measurement on the NanoDrop (A 260/230 nm and A 260/280 nm had to be greater than 1.8) and a run on the Agilent Bioanalyser2100 (RIN values had to be higher than 7). The samples were then labelled using the miRCURY Hy3/ Hy5 power labelling kit (Exiqon) and hybridized on the miRCURY LNA Array (v.11.0) (Exiqon). Labelling was determined to be successful when all capture probes for the control spike-in oligonucleotides produced signals in the expected range. The quantified signals were normalized using the global Lowess (locally weighted scatterplot smoothing) regression algorithm. Blastocyst injections. 2n and 4n blastocyst injections were performed as described before 11 . Briefly, female BDF1 mice were superovulated by intraperitoneal injection of PMS and hCG and mated to BDF1 stud males. Zygotes were isolated from females with a vaginal plug 24 h after hCG injection. Zygotes for 2n injections were in vitro cultured for 3 days in vitro in KSOM media, blastocysts were identified, injected with ES cells or iPSCs and transferred into pseudopregnant recipient females. For 4n injections, zygotes were cultured overnight until they reached the 2-cell stage, at which point they were electrofused. One hour later, 1-cell embryos were carefully identified and separated from embryos that had failed to fuse, cultured in KSOM for another 2 days and then injected. Nuclear transfer. Nuclear transfer was performed as previously described 42 . Briefly, donor iPSCs were cultured in collagen-coated dishes without a feeder layer for 3 days in standard ES cell medium. To synchronize cells at metaphase, the cultures were cultured for 2 h in a medium containing 0.4 mg ml 21 nocodazole (Sigma-Aldrich), a microtubule polymerization inhibitor. Cells floating in the medium were collected. While being sucked into a transfer pipette, only the cells arrested at metaphase were selected and used as nuclear donors. The recipient oocytes were collected from mature B6CBF1 female mice. Micromanipulations were performed in M2 medium containing 5 mg ml 21 cytochalasin B (Sigma) and 1 mg ml 21 nocodazole in a micromanipulation chamber. Explantation of cloned blastocysts and ES-cell derivation was done as described previously 42 . Chromatin immunoprecipitation. 20 million iPSCs, ES cells or MEFs were fixed with 1% formaldehyde for 10 min at 25 uC and then lysed in 1 ml lysis buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 1% SDS, protease inhibitors) for 20 min on ice. The lysate was split into three tubes and sonicated using Bioruptor for five times 5 min at high intensity, 30 s on 230 s off. After 10 min centrifugation, the supernatant was pre-cleared for 1 h at 4 uC with agarose beads pre-blocked with BSA (1 mg BSA for 10 ml beads) in IP buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 2 mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, protease inhibitors). A total of 100 ml of pre-cleared chromatin per reaction diluted in 1 ml IP buffer in the presence of 2 mg antibody was used for each immunoprecipitation reaction according to the manufacturer's protocol. The antibodies used for this study were: anti-acH3 (06-599 Millipore), anti-acH4 (06-866, Millipore), anti-dimethyl K4 of H3 (07-030, Millipore), anti-trimethyl K27 of H3 (ab6002, Abcam) and normal rabbit IgG (Millipore). The precipitate was purified using Qiaquick PCR purification kit and was analysed by qPCR using Brilliant II SYBR Green qPCR Master Mix (600828, Agilent Technologies) using the sequence specific primer sets. Gtl2, 59-AGCCCCTGACTGATGT TCTG-39 (forward) and 59-TGGAAGGGCGATTGGTAGAC-39 (reverse); and Pou5f1, 59-GGAGGTGCAATGGCTGTCTTGTCC-39 (forward) and 59-CTGC CTTGGGTCACCTTACACCTCAC-39 (reverse). In situ hybridization. MEFs grown on coverslips were fixed with 4% formaldeyde/5% acetic acid in PBS for 15 min at 25 uC. After extensive PBS washes, they were dehydrated in 70% ethanol and left overnight at 4 uC. The next day, they were rehydrated in a series of ethanol dilutions and incubated in hybridization buffer (50% formamide-5X SSC-RNase inhibitors) for 1 h at 65 uC. The hybridization was done overnight in a humidified chamber using 400 ng of sense or antisense Gtl2-specific probe per ml of hybridization buffer. The sense and antisense probes were synthesized by in vitro transcription with DIG RNA labelling mix (Roche) and SP6 and T7 polymerase, respectively, using Gtl2 cDNA
